For the Inventor, By the Inventor

Enter assignee name

Sarasota, FL, United States of America

Bridge Pharma Inc.

USPTO Granted Patents = 34

% Expired Patents = 52.9

CIPO Patents = 3

EPO Patents = 7

Forward Citations = 263

Loading Chart...

Loading Chart...

15 inventors (with patents filed for the assignee):

A K Gunnar Aberg (23 out of 24 patents)

Vincent B Ciofalo (10 out of 10 patents)

Ak Gunnar Aberg (7 out of 8 patents)

4. Jan L Chen (7 out of 7 patents)

5. George Edward Wright (7 out of 21 patents)

6. Keith Johnson (4 out of 22 patents)

7. Andrew T Maioli (4 out of 4 patents)

8. Kresimir Pucaj (2 out of 2 patents)

9. Karl Reuter (2 out of 21 patents)

10. Viktor Meier (2 out of 8 patents)

11. Florian Stolz (2 out of 14 patents)

12. Eliso Gogritchiani (2 out of 2 patents)

13. Gunnar Aberg (2 out of 13 patents)

14. A K Aberg (2 out of 9 patents)

15. Paul J Fawcett (1 out of 1 patent)

34 patents: Sort by Forward Citations

1. 11197851 - Methods of treatment of asthma and COPD (2021-12-14),

2. 10959992 - Methods of treatment of asthma and COPD (2021-03-30),

3. 9808419 - Medicinal treatment of dermal infectious disorders with norketotifen (2017-11-07),

4. 9694003 - Formulations and methods for treating high intraocular pressure (2017-07-04),

5. 9439895 - Methods of treating pruritic conditions mediated through non-histaminergic mechanisms in diabetic patients (2016-09-13),

6. 9345697 - Methods of treatment of non-histaminic pruritus (2016-05-24),

7. 9333199 - Methods of treatment of histamine H-4 receptor-related pruritus associated with nerve disorders (2016-05-10),

8. 9138431 - Methods of treatment of histamine H-4 receptor-related pruritus (2015-09-22),

9. 8969385 - Ocular formulations of norketotifen (2015-03-03),

10. 8778971 - Medicinal treatment of dermal diseases in companion animals (2014-07-15),

11. 8765787 - Methods of treatment of xerophthalmia with self-preserving ocular formulations of norketotifen (2014-07-01),

12. 8741930 - Treating xerophthalmia with norketotifen (2014-06-03),

13. 8557846 - Medicinal treatment of dermal diseases in dogs (2013-10-15),

14. 8445542 - Methods of accelerating muscle growth, decreasing fat deposits and improving feed efficiency in livestock animals (2013-05-21),

15. 8383685 - Use of RR/SR-ractopamine (2013-02-26),

Bridge Pharma Inc. is a leading pharmaceutical company specializing in the development and manufacturing of high-quality pharmaceutical products. With our state-of-the-art facilities and a team of experienced professionals, we are committed to delivering innovative solutions to improve global health. Our focus is on developing safe and effective medications across various therapeutic areas. Visit our website for more information about our products, services, and collaborations.

This text is generated by artificial intelligence and may not be accurate.

Company Badge

USPTO Data Jan 1 1976 - Sep 29 2026

34 Patents

#9 in Sarasota, FL

#243 in Florida

#9,991 in US

#19,594 in the World

Sarasota, FL, United States of America

Bridge Pharma Inc.

Forward Citations = 263

15 inventors:

A K Gunnar Aberg (23 out of 24 patents)

Vincent B Ciofalo (10 out of 10 patents)

Ak Gunnar Aberg (7 out of 8 patents)

4. Jan L Chen (7 out of 7 patents)

5. George Edward Wright (7 out of 21 patents)

Please report any incorrect information to [email protected]

Loading…